Literature DB >> 12028038

Reduced platelet adhesion in flowing blood to fibrinogen by alterations in segment gamma316-322, part of the fibrin-specific region.

Jasper A Remijn1, Martin J W IJsseldijk, Bettien M van Hemel, Dennis K Galanakis, Kelly A Hogan, Karim C Lounes, Susan T Lord, Jan J Sixma, Philip G de Groot.   

Abstract

The interaction of platelets with fibrinogen is a key event in the maintenance of a haemostatic response. It has been shown that the 12-carboxy-terminal residues of the gamma-chain of fibrinogen mediate platelet adhesion to immobilized fibrinogen. These studies, however, did not exclude the possibility that other domains of fibrinogen are involved in interactions with platelets. To obtain more insight into the involvement of other domains of fibrinogen in platelet adhesion, we studied platelet adhesion in flowing blood to patient dysfibrinogen Vlissingen/Frankfurt IV (V/FIV), to several variant recombinant fibrinogens with abnormalities in the gamma-chain segments gamma318-320 and gamma408-411. Perfusion studies at physiological shear rates showed that platelet adhesion was absent to gammaDelta408-411, slightly reduced to the heterozygous patient dysfibrinogen V/FIV and strongly reduced to the homozygous recombinant fibrinogens: gammaDelta319-320, gamma318Asp-->Ala and gamma320Asp-->Ala. Furthermore, antibodies raised against the sequences gamma308-322 and gamma316-333 inhibited platelet adhesion under shear conditions. These experiments indicated that the overlapping segment gamma316-322 contains amino acids that could be involved in platelet adhesion to immobilized fibrinogen under flow conditions. In soluble fibrinogen, this sequence is buried inside the fibrinogen molecule and becomes exposed after polymerization. In addition, we have shown that this fibrin-specific sequence also becomes exposed when fibrinogen is immobilized on a surface.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12028038     DOI: 10.1046/j.1365-2141.2002.03467.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  6 in total

1.  Integrin alphaIIbbeta3:ligand interactions are linked to binding-site remodeling.

Authors:  Roy R Hantgan; Mary C Stahle; John H Connor; David A Horita; Mattia Rocco; Mary A McLane; Sergiy Yakovlev; Leonid Medved
Journal:  Protein Sci       Date:  2006-08       Impact factor: 6.725

2.  Ligand density dramatically affects integrin alpha IIb beta 3-mediated platelet signaling and spreading.

Authors:  Markéta Jirousková; Jyoti K Jaiswal; Barry S Coller
Journal:  Blood       Date:  2007-03-01       Impact factor: 22.113

3.  The interaction of integrin αIIbβ3 with fibrin occurs through multiple binding sites in the αIIb β-propeller domain.

Authors:  Nataly P Podolnikova; Sergiy Yakovlev; Valentin P Yakubenko; Xu Wang; Oleg V Gorkun; Tatiana P Ugarova
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

4.  αIIbβ3 binding to a fibrinogen fragment lacking the γ-chain dodecapeptide is activation dependent and EDTA inducible.

Authors:  Hina Zafar; Yi Shang; Jihong Li; George A David; Joseph P Fernandez; Henrik Molina; Marta Filizola; Barry S Coller
Journal:  Blood Adv       Date:  2017-02-22

5.  The Platelet Integrin αIIbβ3 Differentially Interacts with Fibrin Versus Fibrinogen.

Authors:  Rustem I Litvinov; David H Farrell; John W Weisel; Joel S Bennett
Journal:  J Biol Chem       Date:  2016-02-10       Impact factor: 5.157

6.  Dynamic regulation of fibrinogen: integrin αIIbβ3 binding.

Authors:  Roy R Hantgan; Mary C Stahle; Susan T Lord
Journal:  Biochemistry       Date:  2010-11-02       Impact factor: 3.162

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.